Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Buy
12,045
+209
+2% +$24.1K 0.94% 41
2025
Q4
$1.25M Sell
11,836
-219
-2% -$20.6K 0.81% 45
2025
Q3
$1.01M Sell
12,055
-88
-0.7% -$7.25K 0.67% 46
2025
Q2
$962K Buy
12,143
+8
+0.1% +$636 0.67% 49
2025
Q1
$1.09M Buy
12,135
+917
+8% +$85.6K 0.83% 45
2024
Q4
$1.11M Buy
11,218
+234
+2% +$24.1K 0.87% 43
2024
Q3
$1.25M Buy
+10,984
New +$1.3M 0.93% 45
2021
Q4
Sell
-800
Closed -$60K 95
2021
Q3
$60K Hold
800
0.04% 87
2021
Q2
$62K Sell
800
-42,685
-98% -$3.17M 0.04% 117
2021
Q1
$3.21M Sell
43,485
-44,904
-51% -$3.31M 0.33% 81
2020
Q4
$6.85M Buy
88,389
+44,047
+99% +$3.37M 0.72% 37
2020
Q3
$3.49M Buy
44,342
+39,994
+920% +$3.13M 0.39% 64
2020
Q2
$318K Sell
4,348
-43,028
-91% -$3.24M 0.04% 194
2020
Q1
$3.45M Sell
47,376
-13,391
-22% -$1.05M 0.54% 53
2019
Q4
$5.28M Buy
60,767
+36,253
+148% +$2.98M 0.7% 34
2019
Q3
$1.96M Sell
24,514
-22,108
-47% -$1.77M 0.27% 88
2019
Q2
$3.73M Buy
46,622
+45,155
+3,078% +$3.46M 0.43% 66
2019
Q1
$116K Hold
1,467
0.02% 301
2018
Q4
$106K Hold
1,467
0.01% 337
2018
Q3
$99K Buy
+1,467
New +$93.5K 0.01% 366

Other funds holding MRK

Banco de Sabadell's MRK Position: Q1 2026 in Review

Banco de Sabadell increased its Merck (MRK) stake by 1.8% in Q1 2026, buying an estimated $24.1K and bringing the position to 12,045 shares worth $1.42M. The position accounts for 0.94% of the portfolio, ranked #41.

Banco de Sabadell first reported a position in MRK in Q3 2018 and has held it in 20 quarters since. The position peaked at $6.85M in Q4 2020. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Banco de Sabadell held 12,045 shares of Merck worth $1.42M as of Q1 2026.
  • Banco de Sabadell bought 209 Merck shares in Q1 2026, an estimated $24.1K.
  • Merck made up 0.94% of Banco de Sabadell's portfolio in Q1 2026, its #41 holding.
  • Banco de Sabadell first reported a position in Merck in Q3 2018 and has held it in 20 quarters since.
  • Banco de Sabadell's Merck position peaked at $6.85M in Q4 2020.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Banco de Sabadell's 13F filing for Q1 2026, filed 8 May 2026.